Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation [NA]
This completed clinical trial evaluated remote magnetic navigation for guiding cavotricuspid isthmus ablation in atrial flutter.
-
FDA approval · 2009-12-16FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride filed by Wilshire Pharmaceuticals, Inc.
-
FDA approval · 2009-12-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for verapamil hydrochloride by Mylan Pharmaceuticals Inc., enabling the generic version to be market…
-
FDA approval · 2009-12-01FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) by Upsher-Smith Laboratories, LLC, indicating a labeling or …
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Prevention of Atrial Tachycardia After a Right Atriotomy II [Phase 2]
Phase 2 trial evaluating prevention of atrial tachycardia after a right atriotomy in patients with atrial flutter has completed. The update …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-09-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's verapamil hydrochloride as an original generic application, adding a new generic calcium channel blocker to the mark…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Concentrations of Amiodarone in Fat Tissue During Chronic Treatment [Phase 4]
Phase 4 trial investigating concentrations of amiodarone in fat tissue during chronic therapy in patients with arrhythmias, including atrial…
-
FDA approval · 2009-07-20FDA Approved: DIGOXIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the Amneal Pharmaceuticals of New York LLC original application for digoxin (generic digoxin). This approves a generic version …
-
FDA approval · 2009-07-09FDA Approved: FLECAINIDE ACETATE — Original Application (Chartwell RX, LLC)
FDA approved flecainide acetate under an Original Application (ANDA) for Chartwell RX, LLC, enabling a generic version of this antiarrhythmi…
-
FDA approval · 2009-07-02FDA Approved: SOTALOL HYDROCHLORIDE — Original Application (ALTATHERA Pharmaceuticals, LLC)
FDA approved ALTATHERA Pharmaceuticals' original application for sotalol hydrochloride, a beta-blocker used to manage certain arrhythmias.
-
FDA approval · 2009-07-01FDA Approved: MULTAQ — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved MULTAQ (dronedarone) from Sanofi-Aventis U.S. LLC as the original application. It is indicated to reduce the risk of cardiovasc…
-
FDA approval · 2009-06-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2009-06-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., granting additional regulator…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Antero-posterior Versus Antero-lateral Electrode Position for Electrical Cardioversion of Typical Atrial Flutter [NA]
A trial comparing anterior-posterior versus antero-lateral electrode positions for electrical cardioversion in typical atrial flutter was te…
-
FDA approval · 2009-01-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited, approving this generic product for marketing…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence [Phase 2]
A Phase 2 trial evaluating RSD1235-SR for preventing recurrence of atrial fibrillation and atrial flutter has completed.
-
FDA approval · 2008-12-17FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original application for diltiazem hydrochloride (generic). This approval makes a generic vers…
-
FDA approval · 2008-12-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., formally updating the approva…
-
CLINICAL_TRIALS research · 2008-09-16Clinical Trial Update: Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters [NA]
This clinical trial update compares 4 mm versus 2 mm irrigated catheters for ablation in patients with typical atrial flutter.
-
FDA approval · 2008-09-16FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved AMIODARONE HYDROCHLORIDE from Zydus Lifesciences Limited under an original generic application.
-
FDA approval · 2008-07-17FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride Extended-Release from Endo USA, Inc., resulting in an approved update to…
-
CLINICAL_TRIALS trial_result · 2008-04-02Clinical Trial Update: A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter [Phase 2, Phase 3]
An update on a Phase II/III study evaluating RSD1235 for atrial flutter, focusing on tolerance and efficacy. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter [Phase 3]
Phase 3 clinical trial evaluating the response and effectiveness of RSD1235 in patients with atrial fibrillation or atrial flutter has compl…
-
CLINICAL_TRIALS research · 2008-03-19Clinical Trial Update: Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter [Phase 4]
Clinical trial update for a randomized Phase 4 study comparing radiofrequency ablation versus cryoablation in typical isthmus-dependent atri…
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery [Phase 3]
Phase 3 clinical trial evaluating RSD1235 versus placebo for atrial fibrillation or atrial flutter after heart surgery has completed.